Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof
AssigneeChongqing Lummy Pharmaceutical Co., Ltd.
InventorsXiaohai Tang, Yu Qiu
Life of this patent
Estimating the term…
Loading patent…
AssigneeChongqing Lummy Pharmaceutical Co., Ltd.
InventorsXiaohai Tang, Yu Qiu
Estimating the term…
The invention belongs to the pharmaceutical field, and particularly relates to a lyophilized formulation of pectin-adriamycin conjugate and a preparation method thereof. In order to solve insolubility problem of the pectin-adriamycin conjugate (hereinafter referred to as PAC), improve bioavailability and facilitate preparation, the inventor prepared the PAC into a nanosuspension. However, as long-term stability of the nanosuspension is poor, the inventor proposed to prepare the nanosuspension into a lyophilized formulation, that is, an insoluble pectin-adriamycin conjugate is prepared into a suspension or nanosuspension, and a lyophilized support agent is added to the suspension for lyophilization treatment to prepare the lyophilized formulation. Lyophilized products prepared from the nanosuspension are characterized by enhanced stability of nano-particle size and enhanced stability of drug loading rate, which provides a new solution for clinical application of the PAC.
A lyophilized formulation of pectin-adriamycin conjugate prepared by a process comprising preparing a suspension or a nanosuspension containing an insoluble pectin-adriamycin conjugate and a lyophilized support agent, and lyophilizing the suspension or nanosuspension to prepare the lyophilized formulation.
Dependencies are inferred from the claim text.